Abstract
The catalytic α-subunits of Na,K- and H,K-ATPase require an accessory β-subunit for proper folding, maturation, and plasma membrane delivery but also for cation transport. To investigate the functional significance of the β-N terminus of the gastric H,K-ATPase in vivo, several N-terminally truncated β-variants were expressed in Xenopus oocytes, together with the S806C α-subunit variant. Upon labeling with the reporter fluorophore tetramethylrho da mine-6-maleimide, this construct can be used to determine the voltage-dependent distribution between E1P/E2P states. Whereas the E1P/E2P conformational equilibrium was unaffected for the shorter N-terminal deletions βΔ4 and βΔ8, we observed significant shifts toward E1P for the two larger deletions βΔ13 and βΔ29. Moreover, the reduced ΔF/F ratios of βΔ13 and βΔ29 indicated an increased reverse reaction via E2P → E1P + ADP → E1 + ATP, because cell surface expression was completely unaffected. This interpretation is supported by the reduced sensitivity of the mutants toward the E2P-specific inhibitor SCH28080, which becomes especially apparent at high concentrations (100 μm). Despite unaltered apparent Rb+ affinities, the maximal Rb+ uptake of these mutants was also significantly lowered. Considering the two putative interaction sites between the β-N terminus and α-subunit revealed by the recent cryo-EM structure, the N-terminal tail of the H,K-ATPase β-subunit may stabilize the pump in the E2P conformation, thereby increasing the efficiency of proton release against the million-fold proton gradient of the stomach lumen. Finally, we demonstrate that a similar truncation of the β-N terminus of the closely related Na,K-ATPase does not affect the E1P/E2P distribution or pump activity, indicating that the E2P-stabilizing effect by the β-N terminus is apparently a unique property of the H,K-ATPase.
The gastric H,K-ATPase fulfills the remarkable task of pumping protons against a more than 106-fold concentration gradient. H+ extrusion is coupled to countertransport of an equal number of K+ ions for each ATP molecule hydrolyzed, resulting in an electroneutral overall process (1). Characteristic for all P-type ATPases, the enzyme cycles between the two principal conformational states (E1 and E2) and the corresponding phosphointermediates (E1P and E2P), which are formed by reversible phosphorylation of an aspartate residue in the highly conserved DKTGTLT motif. According to a Post-Albers-like reaction scheme (see Fig. 1A), the conformational E1P → E2P transition converts the high H+/low K+ affinity of the cation binding pocket into a low H+/high K+ affinity binding site, hence enabling proton release into the stomach lumen and subsequent binding of extracellular K+. Because the pump faces a lumenal proton concentration of ∼150 mm (2), proton release is probably the energetically most demanding step in the reaction cycle. Thus, during the conformational E1P → E2P transition, enormous pKa changes of the H+-coordinating residues have to occur that most likely involve the rearrangement of a positively charged lysine side chain (Lys-791 in rat H,K-ATPase) (3).
All P2-type ATPases share a common catalytic α-subunit, composed of 10 transmembrane domains harboring the ion-binding sites and a large cytoplasmic loop with the nucleotide-binding domain, the phosphorylation domain (P-domain),2 and the actuator domain (A-domain) (4). However, a unique feature of K+-transporting Na,K- and H,K-ATPase enzymes is the requirement for an accessory β-subunit, which is indispensable for proper folding, maturation, and plasma membrane delivery (5, 6). Despite only 20–30% overall sequence identity between the H,K-ATPase β-subunit and the Na,K β-isoforms, the topogenic structure is similar: a short N-terminal cytoplasmic tail, followed by a single transmembrane segment and a large extracellular C-terminal domain with glycosylation sites and disulfide-bridging cysteines. Numerous studies have demonstrated that the β-subunit of the Na,K-ATPase is more than just a chaperone for the α-subunit, being also required for proper ion transport activity of the holoenzyme. In fact, it has been discovered that different cell- and tissue-specific β-isoforms have distinct effects on the cation affinities (7–9). Furthermore, it was shown that mutational changes in all three topogenic domains of the Na,K-ATPase β-subunit (10–19) as well as chemical interference with disulfide-forming cysteines in the Na,K-ATPase β-subunit ectodomain (20–22) affect the cation transport properties of the sodium pump. Finally, conformational changes in the β-subunit during the Na,K-ATPase reaction cycle were demonstrated by proteolytic digestion studies (23) and voltage clamp fluorometry (24).
Far less is known about the functional significance of the single H,K-ATPase β-isoform, especially about its potential impact on cation transport (reviewed in Refs. 25 and 26). We have proven recently that E2P state-specific transmembrane interactions between residues in αTM7 and two highly conserved tyrosines in the βTM of both Na,K- and H,K-ATPase significantly stabilize the E2P conformation (19). Mutational disruptions of this interaction resulted in substantial shifts toward E1P and severely affected H+ secretion, which highlighted the physiological relevance of this E2P state stabilization. Notably, according to the recently published cryo-EM structure of pig gastric H,K-ATPase in the pseudo-E2P state (27), the N-terminal tail of the β-subunit makes direct contact with the phosphorylation domain of the α-subunit (see Fig. 1B), thus indicating an additional E2P state stabilization mediated by the β-N terminus. Although this idea was further supported by biochemical studies on N-terminally truncated mutants, direct evidence for this putative E2P-stabilizing interaction and its potential significance for ion transport in intact cells is still lacking.
Here, we demonstrate for the first time the functional importance of the gastric H,K-ATPase β-subunit N terminus in living cells under in vivo conditions: voltage clamp fluorometry, Rb+ flux, and SCH28080 sensitivity measurements revealed E1P-shifted, ion transport-impaired phenotypes for two N-terminally truncated H,K β-variants, thus substantiating the E2P-stabilizing effect of the β-N terminus suggested by the recent cryo-EM structure.
EXPERIMENTAL PROCEDURES
Molecular Biology and Oocyte Preparation
The cDNAs of the rat gastric H,K-ATPase β-subunit and a modified form of the α-subunit with a single cysteine replacement in the M5/M6 extracellular loop (S806C; Fig. 1B) were subcloned into vector pTLN (28). This cysteine replacement enables environmentally sensitive TMRM labeling of gastric H,K-ATPase (29) without affecting its transport properties (30). For Na,K-ATPase studies, an ouabain-insensitive sheep Na,K-ATPase α1-mutant (carrying mutations Q111R and N122D (31)) without extracellularly exposed cysteines (mutations C911S and C964A (32)) and a Na,K-ATPase β1-subunit variant (β1S62C) that can be site-specifically labeled with TMRM (24) were used as templates for mutagenesis and cRNA preparation.
N-terminally truncated β-constructs were generated by recombinant PCR and verified by DNA sequencing. Oocyte preparation, cRNA synthesis, and injection were performed as described previously (30). Prior to experiments that were usually carried out 2 or 3 days after injection at 21–24 °C, the oocytes were preincubated in solutions containing 100 μm ouabain (Sigma-Aldrich) to inhibit the endogenous Xenopus Na,K-ATPase.
Voltage Clamp Fluorometry
Site-specific labeling of H,K (or Na,K)-ATPase-expressing oocytes was achieved by incubating oocytes in HK7.4 buffer (90 mm NaCl, 20 mm tetraethylammonium chloride, 5 mm BaCl2, 5 mm NiCl2, 10 mm MOPS/Tris, pH 7.4) containing 5 μm TMRM (Molecular Probes) for 5 min at room temperature in the dark, followed by extensive washes in dye-free HK7.4 buffer. Voltage clamp fluorometry measurements were carried out under high extracellular Na+/K+-free conditions for the characterization of H,K-ATPase mutants in HK5.5 buffer (90 mm NaCl, 20 mm tetraethylammonium chloride, 5 mm BaCl2, 5 mm NiCl2, 10 mm MES/Tris, pH 5.5, 100 μm ouabain) and for Na,K-ATPase-expressing oocytes in NaK7.4 buffer (100 mm NaCl, 5 mm BaCl2, 5 mm NiCl2, 10 mm Hepes, pH 7.4, 100 μm ouabain), respectively. Details on setup components, data acquisition, and analysis are given in Ref. 19.
Rb+ Uptake Measurements
The oocytes were incubated for 15 min in Rb+ flux buffer (5 mm RbCl, 85 mm tetramethylammonium chloride, 20 mm tetraethylammonium chloride, 5 mm BaCl2, 5 mm NiCl2, 10 mm MES, pH 5.5, 100 μm ouabain). After three washing steps in Rb+-free washing buffer (90 mm tetramethylammonium chloride or NaCl, 20 mm tetraethylammonium chloride, 5 mm BaCl2, 5 mm NiCl2, 10 mm MES, pH 5.5) and one wash in water, each individual oocyte was homogenized in 1 ml of Millipore water. For SCH28080 inhibition experiments, the K+-competitive inhibitor SCH28080 (Sigma-Aldrich) was added to the preincubation solution and Rb+ flux buffer (to a final concentration of either 10 μm or 100 μm), respectively. To determine the apparent constant K0.5 for half-maximal activation of the H,K-ATPase by rubidium, the sum [tetramethylammonium chloride] plus [RbCl] in the Rb+ flux buffer was kept constant at 90 mm, e.g. 1 mm RbCl + 89 mm tetramethylammonium chloride. After subtraction of the average Rb+ uptake into control oocytes from the same batches at a given [RbCl], the data were fitted to a Michaelis-Menten type function (Equation 1).
Aliquots of 20 μl from oocyte homogenates were analyzed by atomic absorption spectroscopy using an AAnalyst800TM spectrometer (PerkinElmer Life Sciences), equipped with a transversely heated graphite furnace using a temperature protocol according to the manufacturer's procedures (conditions available on request). Absorption was measured at 780 nm using a rubidium hollow cathode lamp (Photron, Melbourne, Australia). After Zeeman background correction, the Rb+ contents were calculated by comparison with standard calibration curves (measured between 0 and 50 μg/liter Rb+).
Western Blot Analysis of Isolated Plasma Membranes
The procedures for isolation of plasma membranes and total cellular membranes from Xenopus oocytes, gel electrophoresis, and immunoblotting were performed according to the protocols in Ref. 19. The polyclonal antibody HK12.18 (Merck) (6) and the monoclonal antibody 2B6 (MBL, Woburn, MA) (33) were used for detection of gastric H,K-ATPase α- and β-subunits, respectively.
RESULTS AND DISCUSSION
E1P/E2P Conformational Distribution of N-terminally Deleted H,K-ATPase β-Mutants
To investigate whether the N-terminal domain of the β-subunit indeed contributes to E2P state stabilization of the gastric H,K-ATPase, we expressed the wild type β-subunit and four N-terminally deleted H,K β-mutants (Fig. 2A) together with the α-subunit variant S806C in Xenopus oocytes. After site-specific labeling of this cysteine with TMRM (Fig. 1B), monoexponential fluorescence changes were observed upon voltage jumps from a holding potential of −40 mV to values between −180 and +60 mV (Fig. 2B). Hence, this mutant α-subunit directly monitors the voltage-dependent distribution between the E1P/E2P states of H,K-ATPase enzymes, as demonstrated previously (19, 30). Fig. 2C shows the resulting voltage dependence of steady-state fluorescence amplitudes (1 − ΔF/F), which follow a Boltzmann-type distribution for both wild type and β-N-terminally deleted H,K-ATPase enzymes. Whereas these curves were not changed for the shorter N-terminal deletions βΔ4 and βΔ8 compared with βWT, the distributions for the βΔ13 and βΔ29 truncated variants were significantly shifted toward more positive potentials (see Table 1 for Boltzmann parameters), indicating a relative destabilization of the E2P state in favor of E1P. According to these distributions, ∼65% of the βWT and βΔ4- and βΔ8-containing H,K-ATPase molecules occur in the E2P state at −60 mV (which is the physiologically relevant membrane potential determined for parietal cells (34)), but only 60 and 50% of the βΔ29 and βΔ13 mutant enzymes are present in E2P, respectively. Furthermore, the E1P shift is also reflected by the voltage-dependent reciprocal time constants obtained from monoexponential fits to the fluorescence changes (Fig. 2D); of note, these are significantly smaller for the βΔ29 and βΔ13 mutants than for the wild type only at positive potentials, which favor the forward reaction from E1P to E2P, but not at negative potentials, at which the enzyme is driven into the E1P state (via the backward reaction described by krev in Figs. 1A and 2D). Therefore, these N-terminal deletions apparently cause a shift toward E1P by reducing the “forward” rate constant (designated as kfw) of the E1P/E2P transition without changing the rate constant krev for the “reverse” reaction.
TABLE 1.
Boltzmann parameter (1 − ΔF/F)/V curves |
||
---|---|---|
V0.5 | zq | |
mV | ||
HKαS806C/βWT | −110.1 ± 5.0 | 0.33 ± 0.01 |
HKαS806C/βΔ4 | −115.3 ± 5.8 | 0.31 ± 0.01 |
HKαS806C/βΔ8 | −108.7 ± 4.3 | 0.32 ± 0.02 |
HKαS806C/βΔ13 | −56.3 ± 6.3 | 0.34 ± 0.02 |
HKαS806C/βΔ29 | −89.9 ± 4.3 | 0.32 ± 0.01 |
However, if only the results shown in Fig. 2 (C and D) are considered, the conformational effect caused by the N-terminal deletions is probably underestimated because compared with βWT, the two variants βΔ13 and βΔ29 also showed substantially smaller values for the enzyme-specific fluorescence changes ΔF/F (Fig. 2E). Western blot analysis of isolated plasma membranes excluded the possibility that the lower ΔF/F values observed for the βΔ13 and βΔ29 constructs were simply due to a reduced cell surface delivery of the α-subunits that are available for labeling with TMRM (Fig. 2F and supplemental Fig. S1). Therefore, it is safe to assume that the shown ΔF/F ratio is directly proportional to the number of H,K-ATPase molecules that can be shifted between E1P/E2P states by voltage jumps (according to the reaction sequence highlighted in gray in Fig. 1A). The ∼2-fold lower ΔF/F values observed for the βΔ13 and βΔ29 mutants (compared with βWT, βΔ4, and βΔ8) most likely reflect a higher tendency of the mutant H,K-ATPase molecules (that accumulate in the E1P state because of the reduced kfw) to undergo further backward reactions via E1P (H+) → E1P + H+ + ADP → E1 + H+ + ATP. The resulting substantial depletion in the sum of E1P/E2P states would therefore explain the observed smaller fluorescence changes. This interpretation is actually in line with previous results from pulse-chase experiments on purified membranes of H,K-ATPase-expressing HEK293 cells. Compared with the wild type, the membrane fractions containing β-N-terminally truncated variant βΔ8, βΔ13 (27), or βΔ283 showed increased reactivity of radiolabeled E132P-phosphoenzymes with ADP to form [γ-32P]ATP via the aforementioned reverse reaction. Of note, in these chase experiments, already the βΔ8 mutant exhibited a significantly reduced amount of 32P-phosphoenzyme after a 5-s chase with ADP. However, care has to be taken when comparing these and our voltage clamp fluorometry results because of the differences in experimental conditions. The pulse-chase experiments have been performed on membrane fractions at a ubiquitous pH of 6.4, lower ionic strength, and 0 °C, whereas voltage clamp fluorometry probes the enzyme within an intact membrane environment with physiological ion concentrations (and neutral intracellular pH) at room temperature. Differences in the intracellular ion concentration or pH may well affect intramolecular interactions, especially if these interactions involve potentially charged residues (amino acids 6–8 in the N-terminal sequence MAALQEKKSC…). Furthermore, the intracellular ATP and Mg2+ concentrations are by far higher in Xenopus oocytes than in the pulse-chase experiments (2.3 mm ATP (35), 0.5 mm Mg2+ versus 10 μm ATP, 20 μm Mg2+), thus favoring the forward phosphorylation reaction. Therefore, small effects on the E1P/E2P distribution that would reflect enhanced ADP-dependent dephosphorylation of the E1P state of the βΔ8 mutant are possibly obscured under the conditions in living cells.
Rb+ Uptake and SCH28080 Sensitivity of N-terminally Truncated H,K-ATPase β-Subunits
To assess the impact on ion transport activity potentially caused by the conformational shifts of the N-terminally truncated β-variants, we determined Rb+ uptake at saturating extracellular concentrations. Whereas Rb+ uptake for βΔ4- and βΔ8-expressing oocytes was comparable with βWT, it was ∼20% lower for βΔ13 and βΔ29 (Fig. 3A and Table 2). This can be interpreted as a reduced turnover number (lowered vmax) because the apparent affinity for extracellular Rb+ was unaffected by the truncations (see Fig. 3B and Table 2 for apparent K0.5 values). The affected turnover numbers of the βΔ13 and βΔ29 mutants demonstrate that obviously the transition that is characterized by the reduced rate constant kfw of these variants directly affects the rate-limiting step of the catalytic cycle. This illustrates how already small shifts in conformational equilibria can have significant functional consequences for the transport activity of the gastric H,K-ATPase.
TABLE 2.
Normalized Rb+ uptake activity (5 mm RbCl)a,b | Residual Rb+ uptake activity in presence of SCH28080a,c |
Apparent Rb+ affinity (K0.5)d | ||
---|---|---|---|---|
10 μm SCH28080 | 100 μm SCH28080 | |||
% | % | mm | ||
HKαS806C/βWT | 100 ± 3.9 | 21 ± 2.0 | 6 ± 0.7 | 0.66 ± 0.09 |
HKαS806C/βΔ4 | 96 ± 3.3 | 21 ± 1.7 | 14 ± 1.8 | 0.62 ± 0.14 |
HKαS806C/βΔ8 | 95 ± 4.4 | 18 ± 2.0 | 13 ± 2.3 | 0.70 ± 0.18 |
HKαS806C/βΔ13 | 77 ± 4.0 | 28 ± 2.3 | 25 ± 2.6 | 0.65 ± 0.12 |
HKαS806C/βΔ29 | 83 ± 3.8 | 27 ± 2.2 | 20 ± 1.7 | 0.52 ± 0.10 |
Uninjected | 4 ± 0.4 |
a The values are the means ± S.E. of 40–50 oocytes from three or four different oocyte batches.
b The data were normalized to Rb+ uptake of HKαS806C/βWT, corresponding to 32 pmol/min/oocyte.
c The data were normalized to Rb+ uptake at 5 mm RbCl in the absence of SCH28080 for each construct after subtraction of the mean Rb+ uptake of uninjected oocytes.
d The values are the means ± S.E. of 10–20 oocytes.
In the presence of 10 μm SCH28080, an E2P-specific inhibitor of the H,K-ATPase (36–38), the Rb+ uptake of βWT-, βΔ4-, and βΔ8-expressing oocytes was reduced to ∼20% (Fig. 3A, inset, and Table 2), in agreement with the data of Mathews et al. (39). In contrast, the inhibition of ATPase complexes containing βΔ13 and βΔ29 was less efficient, resulting in significantly higher residual activities of ∼30% at 10 μm SCH28080. Notably, 100 μm SCH28080 resulted in a suppression of Rb+ uptake to ∼6% residual activity for HKαS806C/βWT, whereas the effect was much smaller for any of the N-terminally deleted β-variants. As a possible consequence of the E1P-shifted phenotypes of the mutants, the mean dwell time of molecules in the SCH28080-sensitive E2P state may be substantially shorter. Thus, increasing the inhibitor concentration would not result in enhanced binding of the compound because the dwell time in E2P is not sufficient to reach binding equilibrium under turnover conditions. In contrast, the wild type H,K-ATPase, which stays longer in E2P, is able to bind more inhibitor molecules if the SCH28080 concentration is increased. Interestingly, at the higher inhibitor concentration, a significantly reduced SCH28080 sensitivity was also observed for βΔ4- and βΔ8-expressing oocytes, which showed a more than 2-fold higher residual activity compared with βWT (13–14% versus 6%). This suggests that already the shorter deletions cause an elevated preference for E1P, which raises the question of why no effect on the conformational distribution (Fig. 2C) was seen for these constructs. Two possibilities may account for this: (i) minute shifts in the voltage-dependent E1P/E2P distribution may be difficult to resolve by voltage clamp fluorometry experiments because low slope factors zq of the Boltzmann curves limit the accuracy of V0.5 determination, and (ii) E2-destabilizing effects that act on the relative distribution of pump molecules over all reaction intermediates may not be effective during the partial reaction sequence studied in pre-steady-state experiments (voltage clamp fluorometry) but rather become apparent under steady-state conditions (Rb+ uptake), in which the enzyme undergoes the full reaction cycle.
Although the reduction in Rb+ transport activity of βΔ13 and βΔ29 truncated mutants appears moderate, it is important to note that these subtle effects were observed already at a relatively mild proton gradient (pHint ∼ 7.4 versus pHext = 5.5). However, in vivo the H,K-ATPase pumps protons against a 10,000-fold higher gradient of ∼106. Under these physiological conditions (which are unfortunately not applicable to Xenopus oocytes), the high lumenal H+ concentration would even more favor H+ reverse binding at the extracellular sites, thereby also stimulating the E2P → E1P “backward” reaction (i.e. increasing krev). An enhanced krev in addition to the reduced forward rate constant kfw (as observed for the N-terminally deleted mutants βΔ13 and βΔ29) is thus expected to have even more drastic effects on the turnover number. Therefore, although causing only small effects at the rather shallow pH gradient applied here, the E2P state destabilization by the β-N-terminal truncations will almost certainly slow down H+ secretion under the pH conditions in the stomach.
A surprising finding from the current study is that the more extensive deletion βΔ29 caused a smaller shift toward the E1P state than βΔ13 (Fig. 2C and Table 1). The two putative interaction sites between the β-N terminus and the α-subunit proposed by the recently published cryo-EM structure of the pig gastric H,K-ATPase (27) may provide a rationale to explain these rather unexpected effects; apart from the aforementioned contact between the β-N terminus and the P-domain (probably near Arg-716 to Ala-719; see red arrow in Fig. 1B), a stretch of the β-N terminus located closer to the transmembrane domain also approaches the cytoplasmic stalk of αTM3, which is connected to the A-domain (Fig. 1B, black arrow). Therefore, truncation of the first 12 amino acids in βΔ13 may only disrupt the interaction with the P-domain and thereby cause the strong E1P shift, whereas the more extensive deletion in βΔ29 most likely affects both critical contacts, which might involve an additional compensatory mechanism (see below).
As outlined by Abe et al. (27), the contact between the β-subunit N terminus and the P-domain probably stabilizes the enzyme in E2P, thereby minimizing the reverse reaction with ADP via E2P → E1P + ADP → E1 + ATP in terms of a “ratchet”-like mechanism. In the pseudo-E2P state revealed by the cryo-EM structure, the nucleotide-binding domain of the α-subunit is retracted far from the P-domain (supplemental Fig. S2). Therefore, reverse transfer of the phosphate (bound to Asp-385 in the P-domain) to ADP (bound to the nucleotide-binding domain) would require a large movement of the P-domain, which is presumably prohibited by the tethering between the P-domain and β-N terminus in the E2 state. In contrast, in a putative E1P state derived from a SERCA-E1AlF4-ADP structure (40), the ADP at the nucleotide-binding domain is in close proximity to the phosphate analogue AlF4− (shown in supplemental Fig. S2), which could thus explain the enhanced ADP rephosphorylation of the E1P-shifted N-terminally deleted β-variants (27).
The interaction of the β-N terminus with the A-domain via the movement of αTM3 may also be functionally significant because the protrusion of the TGES loop from the A-domain into the gap between the N- and P-domains may have a segregating effect, too (supplemental Fig. S2). Although the influence of the β-N/αTM3 contact on positioning of the A-domain is not resolved yet, it seems possible that the missing contact to the β-N terminus via αTM3 (in βΔ29) may lead to unrestricted movement of the A-domain. This may promote the segregating effect of the TGES loop, which could partially compensate for the destabilization of E2P that arises from the missing interaction with the P-domain, thus explaining the less E1P-shifted phenotype of βΔ29 compared with βΔ13.
N-terminal Truncation of the Na,K-ATPase β-Subunit
Notably, according to the recently published crystal structure of the closely related Na,K-ATPase in the Rb+-occluded E2 state (41), there is no indication for similar interactions between the β-N terminus and the α-subunit of the sodium pump. Although the β-N terminus of the Na,K-ATPase was not completely resolved in this structure so that evidence for a similar interaction in the Na,K-ATPase is absent so far, we tried to explore whether the intersubunit interaction mediated by the H,K-ATPase β-N terminus is conserved among P2C-type ATPases. To determine the impact of β-N-terminal truncation on sheep Na,K-ATPase, the eight most N-terminal amino acids of reporter construct β1S62C (24) of the β1-subunit were deleted (Fig. 4A). Because the cytoplasmic β-N terminus of the Na,K-ATPase is shorter than that of the gastric H,K-ATPase, this truncation results in a N-terminal domain comparable in length to the βΔ13 variant of the H,K-ATPase. This N-terminally truncated β-variant, NaKβ1S62CΔ8, was coexpressed with the wild type sheep α1-subunit, labeled by TMRM, and subjected to voltage jumps in a K+-free solution containing 100 mm Na+. The resulting voltage-dependent distribution of fluorescence amplitudes is not significantly different from the one observed for full-length β1S62C-containing Na,K-ATPase complexes (Fig. 4B and Table 3). Furthermore, as inferred from the stationary pump currents at 10 mm K+, the ion transport activity of the Na,K-ATPase is completely unaffected by the β-N-terminal truncation (Fig. 4B, inset). Regarding the comparably shallow Na+ gradient under physiological conditions, an analogous ratchet-like E2P stabilization is probably not necessary to assist Na+ transport of the sodium pump. This further supports our hypothesis that the E2P state stabilization mediated by the H,K-ATPase β-N terminus is unique to facilitate proton transport against the steep proton gradient across the parietal cell membrane, which is ∼10,000-fold higher than the typical transmembrane gradient for Na+ ions. Therefore, the mechanism of E2P state stabilization by the gastric H,K-ATPase β-N terminus appears to be a distinctive property of this enzyme.
TABLE 3.
Boltzmann parameter (1 − ΔF/F)/V curves |
Stationary pump currents at 10 mm KCl | ||
---|---|---|---|
V0.5 | zq | ||
mV | nA | ||
NaKα1WT/β1S62C | −92.7 ± 7.7 | 0.70 ± 0.03 | 221 ± 85 |
NaKα1WT/β1S62CΔ8 | −100.8 ± 7.5 | 0.68 ± 0.03 | 232 ± 38 |
Conclusions
As a key observation, the recently published cryo-EM structure of the gastric H,K-ATPase highlighted the close proximity between the P-domain of the α-subunit and the short N-terminal tail of the β-subunit, suggesting an E2P-stabilizing interaction of the two subunits. The current study on N-terminally truncated β-variants provides direct evidence that the β-N terminus assists in E2P state stabilization and that this is critical for the transport efficiency of the enzyme under in vivo conditions. Because the effects of the mutants were already significant under the relatively shallow H+ gradient (ΔpH ≈2), they may even be more relevant for the enzyme in situ, where a strong E2P preference is essential for efficient H+ release against a ΔpH of ∼6 units. Moreover, because we recently demonstrated an E2P-stabilizing effect of interactions between residues in the transmembrane domain of the H,K-ATPase β-subunit and TM7 of the α-subunit, the two effects exerted by different regions of the β-subunit may synergistically contribute to the functional requirement of E2P state stabilization.
Supplementary Material
Acknowledgments
We thank I. Seuffert for excellent technical assistance, Ernst Bamberg for continuous encouragement, and K. Tani for valuable comments.
This work was supported by Deutsche Forsch ungs ge mein schaft Grant SFB 740 and Cluster of Excellence “UNICAT” and Grants-in aid for Specially Promoted Research and by the Japan New Energy and Industrial Technology Development Organization.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2 and additional references.
K. Abe, unpublished results.
- P-domain
- phosphorylation domain
- TMRM
- tetramethylrhodamine-6-maleimide
- TM
- transmembrane domain
- EM
- electron microscopy
- WT
- wild type
- MES
- 2-(N-morpholino)ethanesulfonic acid
- MOPS
- 3-(N-morpholino)-propanesulfonic acid
- A-domain
- actuator domain.
REFERENCES
- 1.Sachs G., Chang H. H., Rabon E., Schackman R., Lewin M., Saccomani G. (1976) J. Biol. Chem. 251, 7690–7698 [PubMed] [Google Scholar]
- 2.Wallmark B., Lorentzon P., Sachs G. (1990) J. Intern. Med. Suppl. 732, 3–8 [DOI] [PubMed] [Google Scholar]
- 3.Sachs G., Shin J. M., Vagin O., Lambrecht N., Yakubov I., Munson K. (2007) J. Clin. Gastroenterol. 41, S226–S242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Toyoshima C., Nakasako M., Nomura H., Ogawa H. (2000) Nature 405, 647–655 [DOI] [PubMed] [Google Scholar]
- 5.McDonough A. A., Geering K., Farley R. A. (1990) FASEB J. 4, 1598–1605 [DOI] [PubMed] [Google Scholar]
- 6.Gottardi C. J., Caplan M. J. (1993) J. Biol. Chem. 268, 14342–14347 [PubMed] [Google Scholar]
- 7.Jaisser F., Jaunin P., Geering K., Rossier B. C., Horisberger J. D. (1994) J. Gen. Physiol. 103, 605–623 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Blanco G., Mercer R. W. (1998) Am. J. Physiol. Renal Physiol. 275, F633–F650 [DOI] [PubMed] [Google Scholar]
- 9.Crambert G., Hasler U., Beggah A. T., Yu C., Modyanov N. N., Horisberger J. D., Lelièvre L., Geering K. (2000) J. Biol. Chem. 275, 1976–1986 [DOI] [PubMed] [Google Scholar]
- 10.Jaunin P., Jaisser F., Beggah A. T., Takeyasu K., Mangeat P., Rossier B. C., Horisberger J. D., Geering K. (1993) J. Cell Biol. 123, 1751–1759 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Eakle K. A., Kabalin M. A., Wang S. G., Farley R. A. (1994) J. Biol. Chem. 269, 6550–6557 [PubMed] [Google Scholar]
- 12.Noguchi S., Mutoh Y., Kawamura M. (1994) FEBS Lett. 341, 233–238 [DOI] [PubMed] [Google Scholar]
- 13.Geering K., Beggah A., Good P., Girardet S., Roy S., Schaer D., Jaunin P. (1996) J. Cell Biol. 133, 1193–1204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hasler U., Crambert G., Horisberger J. D., Geering K. (2001) J. Biol. Chem. 276, 16356–16364 [DOI] [PubMed] [Google Scholar]
- 15.Hasler U., Wang X., Crambert G., Béguin P., Jaisser F., Horisberger J. D., Geering K. (1998) J. Biol. Chem. 273, 30826–30835 [DOI] [PubMed] [Google Scholar]
- 16.Abriel H., Hasler U., Geering K., Horisberger J. D. (1999) Biochim. Biophys. Acta 1418, 85–96 [DOI] [PubMed] [Google Scholar]
- 17.Shainskaya A., Karlish S. J. (1996) J. Biol. Chem. 271, 10309–10316 [DOI] [PubMed] [Google Scholar]
- 18.Shainskaya A., Schneeberger A., Apell H. J., Karlish S. J. (2000) J. Biol. Chem. 275, 2019–2028 [DOI] [PubMed] [Google Scholar]
- 19.Dürr K. L., Tavraz N. N., Dempski R. E., Bamberg E., Friedrich T. (2009) J. Biol. Chem. 284, 3842–3854 [DOI] [PubMed] [Google Scholar]
- 20.Lutsenko S., Kaplan J. H. (1993) Biochemistry 32, 6737–6743 [DOI] [PubMed] [Google Scholar]
- 21.Kirley T. L. (1990) J. Biol. Chem. 265, 4227–4232 [PubMed] [Google Scholar]
- 22.Kawamura M., Ohmizo K., Morohashi M., Nagano K. (1985) Biochim. Biophys. Acta 821, 115–120 [DOI] [PubMed] [Google Scholar]
- 23.Lutsenko S., Kaplan J. H. (1994) J. Biol. Chem. 269, 4555–4564 [PubMed] [Google Scholar]
- 24.Dempski R. E., Friedrich T., Bamberg E. (2005) J. Gen. Physiol. 125, 505–520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Geering K. (2001) J. Bioenerg. Biomembr. 33, 425–438 [DOI] [PubMed] [Google Scholar]
- 26.Chow D. C., Forte J. G. (1995) J. Exp. Biol. 198, 1–17 [DOI] [PubMed] [Google Scholar]
- 27.Abe K., Tani K., Nishizawa T., Fujiyoshi Y. (2009) EMBO J. 28, 1637–1643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lorenz C., Pusch M., Jentsch T. J. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 13362–13366 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Geibel S., Zimmermann D., Zifarelli G., Becker A., Koenderink J. B., Hu Y. K., Kaplan J. H., Friedrich T., Bamberg E. (2003) Ann. N.Y. Acad. Sci. 986, 31–38 [DOI] [PubMed] [Google Scholar]
- 30.Dürr K. L., Tavraz N. N., Zimmermann D., Bamberg E., Friedrich T. (2008) Biochemistry 47, 4288–4297 [DOI] [PubMed] [Google Scholar]
- 31.Price E. M., Lingrel J. B. (1988) Biochemistry 27, 8400–8408 [DOI] [PubMed] [Google Scholar]
- 32.Hu Y. K., Eisses J. F., Kaplan J. H. (2000) J. Biol. Chem. 275, 30734–30739 [DOI] [PubMed] [Google Scholar]
- 33.Mori Y., Fukuma K., Adachi Y., Shigeta K., Kannagi R., Tanaka H., Sakai M., Kuribayashi K., Uchino H., Masuda T. (1989) Gastroenterology 97, 364–375 [DOI] [PubMed] [Google Scholar]
- 34.Demarest J. R., Machen T. E. (1985) Am. J. Physiol. Cell Physiol. 249, C535–C540 [DOI] [PubMed] [Google Scholar]
- 35.Gribble F. M., Loussouarn G., Tucker S. J., Zhao C., Nichols C. G., Ashcroft F. M. (2000) J. Biol. Chem. 275, 30046–30049 [DOI] [PubMed] [Google Scholar]
- 36.Wallmark B., Sachs G., Mardh S., Fellenius E. (1983) Biochim. Biophys. Acta 728, 31–38 [DOI] [PubMed] [Google Scholar]
- 37.Mendlein J., Sachs G. (1990) J. Biol. Chem. 265, 5030–5036 [PubMed] [Google Scholar]
- 38.Keeling D. J., Taylor A. G., Schudt C. (1989) J. Biol. Chem. 264, 5545–5551 [PubMed] [Google Scholar]
- 39.Mathews P. M., Claeys D., Jaisser F., Geering K., Horisberger J. D., Kraehenbuhl J. P., Rossier B. C. (1995) Am. J. Physiol. Cell Physiol. 268, C1207–C1214 [DOI] [PubMed] [Google Scholar]
- 40.Toyoshima C., Nomura H., Tsuda T. (2004) Nature 432, 361–368 [DOI] [PubMed] [Google Scholar]
- 41.Morth J. P., Pedersen B. P., Toustrup-Jensen M. S., Sørensen T. L., Petersen J., Andersen J. P., Vilsen B., Nissen P. (2007) Nature 450, 1043–1049 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.